Enhanced Induction of T Cell Immunity Using Dendritic Cells Pulsed with HIV Tat and HCMV-pp65 Fusion Protein In Vitro
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Cytotoxic T lymphocytes (CTLs) appear to play an important role in the control and prevention of human cytomegalovirus (HCMV) infection. The pp65 antigen is a structural protein, which has been defined as a potential target for effective immunity against HCMV infection. Incorporation of an 11 amino acid region of the HIV TAT protein transduction domain (Tat) into protein facilitates rapid, efficient entry into cells. Methods: To establish a strategy for the generation of HCMV-specific CTLs in vitro, recombinant truncated N- and C-terminal pp65 protein (pp65 N&C) and N- and C-terminal pp65 protein fused with Tat (Tat/pp65N&C) was produced in E.coli system. Peripheral blood mononuclear cells were stimulated with dendritic cells (DCs)pulsed with pp65 N&C or Tat/pp65 N&C protein and immune responses induced was examined using IFN-γ ELISPOT assay,cytotoxicity assay and tetramer staining. Results: DCs pulsed with Tat/pp65N&C protein could induce higher T-cell responses in vitro compared with pp65N&C. Moreover, the DCs pulsed with Tat/pp65 N&C could stimulate both of CD8＋ and CD4＋ T-cell responses. The T cells induced by DCs pulsed with Tat/pp65 N&C showed higher cytotoxicity than that of pp65-pulsed DCs against autologous lymphoblastoid B-cell line (LCL) expressing the HCMV-pp65antigen. Conclusion: Our results suggest that DCs pulsed with Tat/pp65 N&C protein effectively induced pp65-specific CTL in vitro. Tat fusion recombinant protein may be useful for the development of adoptive T-cell immunotherapy and DC-based vaccines.
Abstract
Background: Cytotoxic T lymphocytes (CTLs) appear to play an important role in the control and prevention of human cytomegalovirus (HCMV) infection. The pp65 antigen is a structural protein, which has been defined as a potential target for effective immunity against HCMV infection. Incorporation of an 11 amino acid region of the HIV TAT protein transduction domain (Tat) into protein facilitates rapid, efficient entry into cells. Methods: To establish a strategy for the generation of HCMV-specific CTLs in vitro, recombinant truncated N- and C-terminal pp65 protein (pp65 N&C) and N- and C-terminal pp65 protein fused with Tat (Tat/pp65N&C) was produced in E.coli system. Peripheral blood mononuclear cells were stimulated with dendritic cells (DCs)pulsed with pp65 N&C or Tat/pp65 N&C protein and immune responses induced was examined using IFN-γ ELISPOT assay,cytotoxicity assay and tetramer staining. Results: DCs pulsed with Tat/pp65N&C protein could induce higher T-cell responses in vitro compared with pp65N&C. Moreover, the DCs pulsed with Tat/pp65 N&C could stimulate both of CD8＋ and CD4＋ T-cell responses. The T cells induced by DCs pulsed with Tat/pp65 N&C showed higher cytotoxicity than that of pp65-pulsed DCs against autologous lymphoblastoid B-cell line (LCL) expressing the HCMV-pp65antigen. Conclusion: Our results suggest that DCs pulsed with Tat/pp65 N&C protein effectively induced pp65-specific CTL in vitro. Tat fusion recombinant protein may be useful for the development of adoptive T-cell immunotherapy and DC-based vaccines.
참고문헌 (22)
- Ho M, "Epidemiology of cytomegalovirus infections", Rev Infect Dis, 12(7), pp.S701~S710 (1990)
- Taylor-Wiedeman J, "Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells", J Gen Virol, 72, pp.2059~2064 (1991)
- Minton EJ, "Human cytomegalovirus infection of the monocytes", macrophages lineage in bone marrow, 1994, pp.68, 4017~4021
- Soderberg-Naucler C, "Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors", Cell, 91, pp.119~126 (1997)
- Mindelson M, "Detection of endogenous human cytomegalovirus in CD34＋ bone marrow progenitors", J Gen Virol, 77, pp.3099~3102 (1996)
- Michelson S, "Interaction of human cytomegalovirus with monocytes", macrophages: a love-hate relationship, 1997, pp.45, 146~158
- Meyers JD, "Risk factors for cytomegalovirus infection after human marrow transplantation", J Infect Dis, 153, pp.478~488 (1986)
- Meyers JD, "Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viraemia", J Infect Dis, 162, pp.373~380 (1990)
- Banchereau J, "Dendritic cells and the control of immunity", Nature, 392, pp.245~ (1998)
- Foster AE, "Large-scale expansion of cytomegalovirus- specific cytotoxic T cells in suspension culture", Biotechnol Bioeng, 85, pp.138~146 (2004)
- Verma IM, "Gene therapy - promises, problems and prospects", Nature, 389, pp.239~242 (1997)
- Nagahara H, "Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration", Nat Med, 41, pp.449~452 (1998)
- Schwarze SR, "In vivo protein transduction: delivery of a biologically active protein into the mouse", Science, 285, pp.1569~1572 (1999)
- Pande H, "Cloning and physical mapping of a gene fragment coding for a 64-kilodalton major late antigen of human cytomegalovirus", Proc Natl Acad Sci USA, 81, pp.4965~4969 (1984)
- Kern F, "Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals", J Infect Dis, 185, pp.1709~1716 (2002)
- Bradford MA, "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding", Anal Biochem, 72, pp.248~254 (1976)
- Gavin MA, "Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes", J Immunol, 151, pp.3971~3980 (1993)
- s MR, "The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL", J Virol, 70, pp.7569~7579 (1996)
- Cho HI, "Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro", J Immunother, 24, pp.242~249 (2001)
- Paston SJ, "Progress made towards the development of a CMV peptide vaccine", Human Immunology, 65, pp.544~549 (2004)
- Fittipaldi A, "Transcellular protein transduction using the Tat protein of HIV-1", Adv Drug Deliv Rev, 57, pp.597~608 (2005)
- Wadia JS, "Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer", Adv Drug Deliv Rev, 57, pp.579~596 (2005)